LY3493269

DRUG4 trials

Sponsors

Eli Lilly and Company

Conditions

Diabetes Mellitus, Type 2Healthy

Phase 1

A Safety Study of LY3493269 in Healthy Participants

CompletedNCT04498390

Eli Lilly and CompanyHealthy

Start: 2020-09-03End: 2020-12-28Updated: 2025-01-14

A Study of LY3493269 in Participants With Type 2 Diabetes

CompletedNCT04515576

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2020-08-25End: 2021-03-09Updated: 2025-01-14

A Study of LY3493269 in Healthy Participants

CompletedNCT04682106

Eli Lilly and CompanyHealthy

Start: 2021-05-03End: 2021-11-11Updated: 2025-01-14

A Multiple-Dose Study of LY3493269 in Healthy Participants

TerminatedNCT05794243

Eli Lilly and CompanyHealthy

Start: 2023-03-23End: 2023-06-20Updated: 2025-01-14